Calian Group (TSE:CGY – Get Free Report) had its price objective boosted by research analysts at Ventum Financial from C$72.00 to C$82.00 in a research report issued on Friday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Ventum Financial’s price objective suggests a potential upside of 15.79% from the company’s previous close.
Several other research analysts have also recently weighed in on CGY. CIBC World Markets lifted their price target on shares of Calian Group from C$65.00 to C$76.00 in a research note on Friday. Canadian Imperial Bank of Commerce boosted their price target on Calian Group from C$62.00 to C$65.00 in a report on Wednesday, January 14th. Royal Bank Of Canada raised their price objective on Calian Group from C$58.00 to C$60.00 and gave the stock an “outperform” rating in a research note on Friday. Canaccord Genuity Group boosted their price objective on Calian Group from C$63.00 to C$80.00 in a research note on Friday. Finally, Desjardins raised their target price on shares of Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Six investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of C$73.43.
View Our Latest Analysis on CGY
Calian Group Stock Performance
Calian Group (TSE:CGY – Get Free Report) last released its quarterly earnings results on Thursday, February 12th. The company reported C$1.03 EPS for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. The firm had revenue of C$208.00 million during the quarter. As a group, equities analysts anticipate that Calian Group will post 4.9475219 earnings per share for the current year.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Articles
- Five stocks we like better than Calian Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
